The effect of subantimicrobial-dose–doxycycline periodontal therapy on serum biomarkers of systemic inflammation
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background Periodontitis has been reported to be associated with coronary artery disease (CAD). Research is needed to determine if therapies that improve periodontal health also reduce systemic measures of inflammation associated with both diseases. Methods 128 postmenopausal women with chronic periodontitis were randomly assigned to twice-daily subantimicrobial dose doxycycline (SDD) or placebo tablets for two years adjunctive to periodontal maintenance therapy. Through a supplement to the main trial investigating alveolar bone and clinical periodontal changes, inflammatory mediators and lipid profiles were assayed in baseline, one- and two-year serum samples. Data were analyzed by generalized estimating equations. Results In the intent-to-treat population over two years, SDD treatment reduced median high-sensitivity C-reactive protein (hs-CRP) by 18% (primary outcome; p=0.02) and reduced serum matrix metalloproteinase-9 (MMP-9; 92 kilodalton gelatinase) (difference in mean scanning units: −28.44; p<0.0001), with no significant effect on serum lipids. However, in women more than five years postmenopausal, SDD elevated high-density lipoprotein (HDL) cholesterol (difference in means [mg/dl]: 5.99; p=0.01). Conclusions A two-year SDD regimen in postmenopausal women significantly reduced the serum inflammatory biomarkers hs-CRP and MMP-9 and, among women more than five years postmenopausal, raised HDL cholesterol. Clinical Implications SDD significantly reduced the systemic inflammatory biomarkers, hs-CRP and MMP-9. More research is needed to determine whether SDD has a role in CAD risk management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Pocock, S. J. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00008-1 · Cited by 184
Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
Elliott, P. (2009) · JAMA · doi:10.1001/jama.2009.954 · Cited by 35
Cited by
Rial, N. S., Choi, K., Nguyen, T., Snyder, B., & Slepian, M. J. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2011.09.034 · Cited by 47
Bortolanza, M., do Nascimento, G. C., Raisman‐Vozari, R., & Del‐Bel, E. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15439 · Cited by 33
The PBRN Initiative: Transforming New Technologies to Improve Patient Care
Curro, F. A., Vena, D., Naftolin, F., Terracio, L., & Thompson, V. P. (2012) · Journal of Dental Research · doi:10.1177/0022034512447948 · Cited by 17
“Further, PEARL is structurally able to participate in dental studies with medical consequences (Payne et al., 2011), Rx to OTC switches, and pharmaco-vigilance, drug safety, and Phase IV studies.”
Background
Metadata
- Authors
- Payne, J. B., Golub, L. M., Stoner, J. A., Lee, H.-M., Reinhardt, R. A., Sorsa, T., & Slepian, M. J.
- Venue
- The Journal of the American Dental Association
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 142
- Issue
- 3
- Pages
- 262-273
- ISSN
- 0002-8177 (ISSN-L)
- OpenAlex
- W9720479
- Cited by
- 83
- References
- 5
- FWCI
- 10.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The effect of subantimicrobial-dose–doxycycline periodontal therapy on serum biomarkers of systemic inflammation. https://app.cochat.ai/papers/10.14219/jada.archive.2011.0165
- The paper
- Payne, J. B., Golub, L. M., Stoner, J. A., Lee, H.-M., Reinhardt, R. A., Sorsa, T., & Slepian, M. J. (2011). The effect of subantimicrobial-dose–doxycycline periodontal therapy on serum biomarkers of systemic inflammation. The Journal of the American Dental Association. https://doi.org/10.14219/jada.archive.2011.0165
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.